Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jan;45(1):152-154.
doi: 10.1007/s00259-017-3859-1. Epub 2017 Oct 27.

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?

G D Flux  1 , K Sjogreen Gleisner  2 , C Chiesa  3 , M Lassmann  4 , N Chouin  5   6 , J Gear  7 , M Bardiès  8 , S Walrand  9 , K Bacher  10 , U Eberlein  3 , M Ljungberg  2 , L Strigari  11 , E Visser  12 , M W Konijnenberg  13
Affiliations
Comment

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?

G D Flux et al. Eur J Nucl Med Mol Imaging. 2018 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

None.

Research involving human participants and animals

None.

Informed consent

No informed consent was needed.

Comment on

References

    1. Giammarile F, Muylle K, Bolton RD, Kunikowska J, Haberkorn U, Oyen W. Dosimetry in clinical radionuclide therapy: the devil is in the detail. Eur J Nucl Med Mol Imaging. 2017; 10.1007/s00259-017-3820-3. - PubMed
    1. Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2017; 10.1007/s00259-017-3707-3. - PubMed
    1. Council Directive 2013/59/Euratom. Off J Eur Union. 2014;57. doi:10.3000/19770677.L_2014.013.eng.
    1. Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Gleisner KS, et al. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy. Eur J Nucl Med Mol Imaging. 2014;41:1976–1988. doi: 10.1007/s00259-014-2824-5. - DOI - PubMed
    1. Garin E, Rolland Y, Pracht M, Le Sourd S, Laffont S, Mesbah H, et al. High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization. Liver Int. 2017;37:101–110. doi: 10.1111/liv.13220. - DOI - PMC - PubMed

LinkOut - more resources